Brief: Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement With Santen Pharmaceutical
07/11/2024 14:08
Nov 7 (Reuters) - Clearside Biomedical Inc CLSD.O :
* CLEARSIDE BIOMEDICAL PARTNER ARCTIC VISION EXECUTES
COMMERCIAL
COLLABORATION AGREEMENT WITH SANTEN PHARMACEUTICAL CO., LTD FOR
ARVN001 SUPRACHOROIDAL SPACE INJECTION THERAPY FOR THE TREATMENT
OF UVEITIC MACULAR EDEMA
* CLEARSIDE BIOMEDICAL INC - NEW DRUG APPLICATIONS FOR
ARVN001
UNDER REVIEW IN AUSTRALIA AND SINGAPORE
Source text: ID:nGNX5Y6JWr
Further company coverage: CLSD.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Clearside Biomedical,
See all newsBrief: Clearside Biomedical Completes Financial Restructuring And Emerges From Chapter 11 With Steel Partners As Plan Sponsor
U.S. STOCKS ON THE MOVE-Merck, Genco, Tesla
U.S. STOCKS ON THE MOVE-Morgan Stanley, Merck, Genco
Clearside Biomedical plunges after filing for Chapter 11 bankruptcy
U.S. STOCKS ON THE MOVE-Bristol Myers Squibb, Palo Alto Networks, MP Materials